BrainStorm Cell Therapeutics
BCLI
#10526
Rank
NZ$13.7 M
Marketcap
NZ$1.24
Share price
-6.49%
Change (1 day)
-38.68%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -NZ$18.73 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$20.05 Million, an increase over its 2023 earnings that were of -NZ$29.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$18.73 Million-6.61%
2024 -NZ$20.05 Million-32.39%
2023 -NZ$29.66 Million-29.18%
2022 -NZ$41.88 Million-0.74%
2021 -NZ$42.19 Million-23.12%
2020 -NZ$54.87 Million36.8%
2019 -NZ$40.11 Million66.71%
2018 -NZ$24.06 Million181.66%
2017 -NZ$8.55 Million-0.6%
2016 -NZ$8.6 Million-41.31%
2015 -NZ$14.64 Million-8.22%
2014 -NZ$15.96 Million89.74%
2013 -NZ$8.41 Million42.27%
2012 -NZ$5.91 Million-12.45%
2011 -NZ$6.75 Million63.04%
2010 -NZ$4.14 Million35.52%
2009 -NZ$3.06 Million-48.99%
2008 -NZ$5.99 Million-44.39%
2007 -NZ$10.77 Million
2005 -NZ$5.58 Million-91.44%
2004 -NZ$65.16 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$2.79 B-15,064.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.89 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.37 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.44 Billion 7,549.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.63 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.45 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA